ROLE OF ANTI-DIABETIC DRUGS AS THERAPEUTIC AGENTS IN ALZHEIMER'S DISEASE

被引:0
作者
Rizvi, Syed Mohd. Danish [1 ]
Shaikh, Sibhghatulla [1 ]
Waseem, Shah Mohammad Abbas [2 ]
Shakil, Shazi [3 ]
Abuzenadah, Adel M. [3 ]
Biswas, Deboshree [1 ]
Tabrez, Shams [4 ]
Ashraf, Ghulam Md. [4 ]
Kamal, Mohammad Amjad [4 ,5 ]
机构
[1] Integral Univ, Dept Biosci, Lucknow, Uttar Pradesh, India
[2] Integral Univ, Dept Physiol, Integral Inst Med Sci & Res, Lucknow, Uttar Pradesh, India
[3] King Abdulaziz Univ, Fac Appl Med Sci, Ctr Innovat Personalized Med, Jeddah 21589, Saudi Arabia
[4] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia
[5] Enzymoic, Hebersham, NSW 2770, Australia
来源
EXCLI JOURNAL | 2015年 / 14卷
关键词
Alzheimer's disease; anti-diabetic drugs; amyloid beta; beta-secretase; sodium glucose; co-transporters; Type 2 Diabetes Mellitus; ACTIVATED-RECEPTOR-GAMMA; MILD COGNITIVE IMPAIRMENT; TYPE-2; DIABETES-MELLITUS; INDUCED CELL-DEATH; A-BETA; PPAR-GAMMA; IN-VITRO; AGONIST PIOGLITAZONE; INSULIN-SECRETION; SIGNALING PATHWAY;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recent data have suggested a strong possible link between Type 2 Diabetes Mellitus and Alzheimer's disease (AD), although exact mechanisms linking the two are still a matter of research and debate. Interestingly, both are diseases with high incidence and prevalence in later years of life. The link appears so strong that some scientists use Alzheimer's and Type 3 Diabetes interchangeably. In depth study of recent data suggests that the anti diabetic drugs not only have possible role in treatment of Alzheimer's but may also arrest the declining cognitive functions associated with it. The present review gives an insight into the possible links, existing therapeutics and clinical trials of anti diabetic drugs in patients suffering from AD primarily or as co-morbidity. It may be concluded that the possible beneficial effects and usefulness of the current anti diabetic drugs in AD cannot be neglected and further research is required to achieve positive results. Currently, several drug trials are in progress to give conclusive evidence based data.
引用
收藏
页码:684 / 696
页数:13
相关论文
共 102 条
[1]   Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: Interaction between type 2 diabetes and Alzheimer's disease [J].
Abbas, Talib ;
Faivre, Emilie ;
Hoelscher, Christian .
BEHAVIOURAL BRAIN RESEARCH, 2009, 205 (01) :265-271
[2]   Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition [J].
Adler, Brittany L. ;
Yarchoan, Mark ;
Hwang, Hae Min ;
Louneva, Natalia ;
Blair, Jeffrey A. ;
Palm, Russell ;
Smith, Mark A. ;
Lee, Hyoung-gon ;
Arnold, Steven E. ;
Casadesus, Gemma .
NEUROBIOLOGY OF AGING, 2014, 35 (04) :793-801
[3]   The potential of anti-inflammatory drugs for the treatment of Alzheimer's disease [J].
Aisen, PS .
LANCET NEUROLOGY, 2002, 1 (05) :279-284
[4]   Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? [J].
Akter, Kawser ;
Lanza, Emily A. ;
Martin, Stephen A. ;
Myronyuk, Natalie ;
Rua, Melanie ;
Raffa, Robert B. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (03) :365-376
[5]   Alzheimer's disease and Type 2 diabetes mellitus: the cholinesterase connection? [J].
Allam, Appa Rao ;
Sridhar, Gumpeny Ramachandra ;
Thota, Hanuman ;
Babu, Changalasetty Suresh ;
Prasad, Akula Siva ;
Divakar, Ch .
LIPIDS IN HEALTH AND DISEASE, 2006, 5 (1)
[6]  
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc11-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S067, 10.2337/dc12-s011, 10.2337/dc10-S011, 10.2337/dc10-S062, 10.2337/dc13-S011, 10.2337/dc12-s064]
[7]  
[Anonymous], PHARMACOGENOMICS J
[8]  
[Anonymous], ALZHEIMER DEMENT
[9]  
[Anonymous], J BIOMED BIOTECHNOL
[10]  
[Anonymous], NAT REV DRUG DISCOV